fbpx

CMS Announces Penalties and Rewards for Promoting Home Dialysis and Transplants

2020-09-22T14:49:34+00:00September 22nd, 2020|Categories: Access to Transplant, Article, Dialysis Funding, Transplant Donor Protection, Treatment Options|

On September 18, the Centers for Medicare & Medicaid Services (CMS) announced it finalized the End-Stage Renal Disease Treatment Choices (ETC) Model. The ETC Model was a cornerstone of President Trump’s Advancing Kidney Health Executive Order in 2019. It encourages an increased use of home dialysis and kidney transplants in approximately 30 percent of dialysis facilities and nephrology practices and will be implemented on January 1, 2021. CMS estimated reduced expenditures of $23 million over five and a half years, anticipating that providers assigned to the program will be penalized for not meeting standards. DPC and many other kidney groups opposed this [...]

DPC Comments on CMS Proposed ESRD Annual Payment Rule to Increase Dialysis Patient Quality Care

2020-09-22T15:12:47+00:00September 1st, 2020|Categories: Access to Transplant, Care Coordination, Comment Letter, Innovation, Medicaid, Medicare Advantage, Quality Incentive Program, Treatment Options|

Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS’ latest policies, and organizations have the opportunity to provide feedback about the rules before they go into effect on January 1. DPC provided feedback to CMS regarding their End-Stage Renal Disease (ESRD) Annual Payment rule. DPC’s letter addresses the following important topics for improving ESRD patient care: Protect Access for Costlier Patients by Completing Reconsideration of Case-Mix Adjusters Protect Access for Patients in Disadvantaged Regions by Addressing Social Risk Factors Focus [...]

DPC’s 2020 Annual Membership Survey is Live!

2020-08-10T14:19:35+00:00August 6th, 2020|Categories: 5-Star Ratings, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Get Involved, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Quality Incentive Program, Take Action, Transplant Donor Protection, Transportation Services, Treatment Options|Tags: |

Elevate the Voice of Patients with Kidney Disease and Their Caregivers Our 2020 Annual Membership Survey is live, and it will remain open until Friday, August 21. We are counting on your participation, as patient feedback helps to shape our public policy agenda and patient education priorities for the next year. This year we ask that both patients and caregivers take our survey. Rest assured your responses will remain completely anonymous. We only share the overall survey results with state and federal level policy makers, so they will better understand your needs, experiences, and preferences. Your feedback is crucial. Therefore, we will [...]

Action Alert – Secure Patient Access to Immunosuppressive Medications

2020-07-28T17:23:22+00:00January 12th, 2020|Categories: Access to Transplant, Article, Immunosuppressive Drug Coverage, Take Action|

The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (H.R. 5534) was recently introduced by Representatives Ron Kind (D-WI) and Michael Burgess (R-TX). This legislation would extend Medicare coverage of immunosuppressant drugs beyond the current limit of 36 months for patients who are unable to obtain health insurance coverage elsewhere. Immunosuppressive medications play a critical role in preventing transplant recipients from rejecting a donor kidney. Right now, after dialysis patients receive a transplant, if they are under the age of 65, they are only eligible to remain on Medicare for an additional 36 months. After this three-year [...]

Happy Holidays and DPC’s Top 10 Accomplishments of 2019

2020-03-21T20:40:48+00:00December 20th, 2019|Categories: 5-Star Ratings, About DPC, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Quality Incentive Program, Transplant Donor Protection, Transportation Services, Treatment Options|

Dialysis Patient Citizens wants to wish you and your family a Happy Holiday, as well as a safe and healthy New Year. Our offices will be closed for the holidays starting December 23 through January 1. We also want to take this opportunity to share our list of Top 10 Accomplishments for 2019, which would not have been possible without your support. Thank you again for helping us elevate the dialysis patient voice with policy makers. We are extremely grateful for all of your advocacy efforts, and we look forward to our continued collaboration in 2020 as we work together to improve dialysis [...]

Congress Comments on CMS Proposed Rule Regarding ESRD Treatment Choices Model Demonstration

2020-03-21T20:41:19+00:00October 18th, 2019|Categories: Access to Transplant, Care Coordination, Comment Letter, News, Treatment Options|

This month Members of Congress reached out to the Centers for Medicare and Medicaid Services (CMS) about the ETC Model, which is the same rule DPC commented on last month that pertains to increasing the number of home dialysis treatments and kidney transplants. In the letter, lawmakers raised concerns that parallel many of the priorities DPC advocates for in order to improve dialysis patient care. Specifically, the letter addressed: Improving access to care and treatment options Promoting patient choice Advancing care coordination Increasing access to transplant With over 70 signatures from legislators supporting the letter, we are pleased to see that [...]

DPC Comments on CMS Proposed ESRD Annual Payment Rule to Improve Dialysis Patient Quality of Life

2020-03-21T20:41:19+00:00October 11th, 2019|Categories: Access to Transplant, Article, Charitable Premium Assistance, Comment Letter, Dental Coverage, Dialysis Funding, Innovation, Medicare Advantage, Quality Incentive Program, Treatment Options|

Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS' latest policies, and organizations have the opportunity to provide feedback about the rules before they go into effect on January 1. DPC provided feedback to CMS regarding their end-stage renal disease (ESRD) Annual Payment rule. DPC's letter addresses the following important topics for improving ESRD patient care: Transitional Add-On Payment Adjustment for New and Innovative Equipment and Supplies Anemia Management Social Risk Factors and their Impact on the QIP The Need [...]

DPC Comments on CMS Proposed Rule Regarding ESRD Treatment Choices Model Demonstration

2020-03-21T20:41:19+00:00September 4th, 2019|Categories: Access to Transplant, Comment Letter, Dental Coverage, Innovation, Medicaid, Transplant Donor Protection, Treatment Options|

In response to the Administration's announcement to improve kidney health in America, the Centers for Medicare and Medicaid Services (CMS) proposed a rule to implement a mandatory Medicare payment model designed to increase the number of home dialysis treatments and kidney transplants, all while reducing Medicare expenditures. The rule—referred to as the End-Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model)—would measure clinician and facility performance, as well as the rate of home dialysis and kidney transplants in selected geographic regions. These calculations would result in either an increase or decrease of Medicare funding to a particular facility or clinician, [...]

The Administration’s Plan to Improve Quality of Life and Patient Choice for Dialysis Patients

2020-03-21T20:41:19+00:00July 11th, 2019|Categories: Access to Transplant, Article, Improve Access to Care, Transplant Donor Protection, Treatment Options|

President Donald J. Trump thanks DPC Board Member Nancy Scott prior to signing an Executive Order on Advancing American Kidney Health Wednesday, July 10, 2019, at the Ronald Reagan Building and International Trade Center in Washington, D.C. (Official White House Photo by Shealah Craighead) "I did dialysis. I did not let it do me." Those powerful words were shared by DPC Board Member Nancy Scott shortly before President Trump signed an Executive Order centered around improving kidney health in America on July 10, 2019. Scott was one of only three individuals who the Administration asked to share her [...]

Medicare Adds Transplant Measure to ESRD Quality Improvement Program

2020-03-21T20:41:51+00:00November 18th, 2018|Categories: Access to Transplant, Article, Quality Incentive Program|

On November 1, 2018, the Centers for Medicare & Medicaid Services (CMS) issued its final annual rule updating payment policies for the End-Stage Renal Disease (ESRD) Prospective Payment System and the ESRD Quality Incentive Program (QIP). Among new quality measures to take effect beginning in 2022 is Percentage of Prevalent Patients Placed on a Transplant Waiting List (PPPW). This measure was already scheduled to be reported for individual clinics, beginning next year, on CMS’ Dialysis Facility Compare website. Adding it to the QIP means that facilities can be penalized if the percentage of their patients waitlisted for transplant is below [...]

Go to Top